Genes, Neurofibromatosis 2
"Genes, Neurofibromatosis 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes NEUROFIBROMATOSIS 2.
MeSH Number(s)
G05.360.340.024.340.375.249.345
G05.360.340.024.340.415.400.345
Concept/Terms
Genes, Neurofibromatosis 2- Genes, Neurofibromatosis 2
- Genes, nf 2
- Gene, nf 2
- nf 2 Gene
- nf 2 Genes
- nf2 Genes
- Neurofibromatosis 2 Genes
- Gene, Neurofibromatosis 2
- Neurofibromatosis 2 Gene
- Genes, nf2
- Gene, nf2
- nf2 Gene
Below are MeSH descriptors whose meaning is more general than "Genes, Neurofibromatosis 2".
Below are MeSH descriptors whose meaning is more specific than "Genes, Neurofibromatosis 2".
This graph shows the total number of publications written about "Genes, Neurofibromatosis 2" by people in Harvard Catalyst Profiles by year, and whether "Genes, Neurofibromatosis 2" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 1 | 4 |
| 1994 | 6 | 0 | 6 |
| 1995 | 7 | 2 | 9 |
| 1996 | 5 | 0 | 5 |
| 1997 | 3 | 1 | 4 |
| 1998 | 8 | 0 | 8 |
| 1999 | 4 | 0 | 4 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 2 | 2 |
| 2015 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
Below are the most recent publications written about "Genes, Neurofibromatosis 2" by people in Profiles.
-
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 2018 06; 135(6):955-963.
-
Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun. 2017 02 14; 8:14433.
-
RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver. J Hepatol. 2016 Apr; 64(4):899-907.
-
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. Eur Urol. 2016 09; 70(3):516-21.
-
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014 Jan 03; 343(6166):84-87.
-
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013 Mar 01; 339(6123):1077-80.
-
Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth. Cancer Res. 2013 Jan 15; 73(2):792-803.
-
TGF-ß synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med. 2012 Mar 12; 209(3):479-94.
-
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia. 2012 Jan; 14(1):20-8.
-
Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. Acta Neuropathol. 2012 Mar; 123(3):369-80.